Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.25
Delayed Data
As of 12:03pm ET
 -0.075 / -2.26%
Today’s Change
2.28
Today|||52-Week Range
4.71
-16.37%
Year-to-Date

Today’s Trading

Previous close3.32
Today’s open3.32
Day’s range3.20 - 3.37
Volume1,326,925
Average volume (3 months)2,452,957
Market cap$552.6M
Data as of 12:03pm ET, 09/21/2018

Growth & Valuation

Earnings growth (last year)+15.07%
Earnings growth (this year)-4.04%
Earnings growth (next 5 years)+108.00%
Revenue growth (last year)-78.00%
P/E ratioNM
Price/Sales109.31
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.17+11.56%
SIGASIGA Technologies In...+0.06+0.89%
ELOXEloxx Pharmaceutical...+0.56+3.66%
REPLReplimune Group Inc+0.05+0.27%
Data as of 12:18pm ET, 09/21/2018

Financials

Next reporting dateNovember 6, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$4.5M
Annual profit (last year)-$78.0M
Net profit margin-1,739.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Raul R. Rodriguez
Chief Financial Officer &
Executive Vice President
Dean L. Schorno
Corporate headquarters
South San Francisco, California

Forecasts